<bill session="116" type="s" number="3271" updated="2020-08-17T21:00:11Z">
  <state datetime="2020-02-11">REFERRED</state>
  <status>
    <introduced datetime="2020-02-11"/>
  </status>
  <introduced datetime="2020-02-11"/>
  <titles>
    <title type="short" as="introduced">Fairness in Orphan Drug Exclusivity Act</title>
    <title type="short" as="introduced">Fairness in Orphan Drug Exclusivity Act</title>
    <title type="display">Fairness in Orphan Drug Exclusivity Act</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001075"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2020-02-11"/>
    <cosponsor bioguide_id="S001181" joined="2020-02-11"/>
  </cosponsors>
  <actions>
    <action datetime="2020-02-11">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-02-11" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="4712"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Competition and antitrust"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Licensing and registrations"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
